Agenda Details

Learn more about sessions and presentations at the 26th Annual Meeting

Detailed Program

Expanding the Genome Editor Toolbox and Translation Towards the Clinic

Genome editing technologies have reshaped our ability to modify genomes, bringing the promise of new therapies for human diseases within reach. In this symposium, speakers will highlight recent technological advances in the toolbox of CRISPR and non-CRISPR enzymes capable of making small and large genetic edits. These diverse platforms are being optimized in the pursuit of building highly precise genome editors with low genotoxicity. Our speakers will also discuss how these technologies will, and already are, having an impact in the clinic.

Session Details


Mark Osborn, PhD. University of Minnesota, Minneapolis, MN


Benjamin P. Kleinstiver. Massachusetts General Hospital & Harvard Medical School, Boston, MA

Prime Editing

Andrew Anzalone, PhD. Prime Medicine, MA

Development and Characterization of Multiplexed Orthogonal Base Editing Systems

Alexis C. Komor, PhD. University of California, San Diego, La Jolla, CA

Writing DNA with RNA: genome engineering by target primed reverse transcription

Cecilia Cotta-Ramusino, PhD. Tessera Therapeutics, MA

From N=1 to N=All: Expanding the Clinical Impact of CRISPR

Fyodor D. Urnov, PhD. University of California, Berkeley, Berkeley, CA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.